Steiner, Sophie http://orcid.org/0000-0002-2217-7566
Schwarz, Tatjana http://orcid.org/0000-0002-6054-4750
Corman, Victor M. http://orcid.org/0000-0002-3605-0136
Jeworowski, Lara M. http://orcid.org/0000-0002-4159-4189
Bauer, Sandra http://orcid.org/0000-0002-3497-4730
Drosten, Christian http://orcid.org/0000-0001-7923-0519
Scheibenbogen, Carmen http://orcid.org/0000-0002-8554-9638
Hanitsch, Leif G. http://orcid.org/0000-0002-8181-0093
Funding for this research was provided by:
Bundesministerium für Forschung und Technologie (VARIPath (01KI2021))
Charité - Universitätsmedizin Berlin
Article History
Received: 23 December 2022
Accepted: 5 March 2023
First Online: 17 March 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Charité, Universitätsmedizin Berlin (EA2/092/20 from June 4th 2020) and with the 1964 Helsinki Declaration and its later amendments.
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for publication of acquired data.
: VMC is named together with Charité—Universitätsmedizin Berlin and Euroimmun GmbH on a patent application (Methods and reagents for diagnosis of SARS-CoV-2 infection. Pub number 20210190797) filed recently regarding the diagnostic of SARS-CoV-2 by antibody testing. The other authors have no relevant financial or non-financial interests to disclose.